[printfriendly]
December 2013—Sequenom has announced a certified service provider program for the technical certification of selected laboratories offering research services using the Sequenom research-use-only MassArray system. Certifications cover the major research applications of the MassArray system, including iPlex genotyping, OncoCarta somatic mutation profiling, ADME PGx, and EpiTyper DNA methylation analysis.
Sequenom’s MassArray system is used by biomedical researchers worldwide to measure genetic variations that occur normally or in association with diseases, including cancer. The MALDI-TOF–based mass spectrometry technology enables scientists to utilize highly specific and sensitive predesigned or custom-made research-use assay panels for several key types of genomic markers, including single nucleotide polymorphisms, somatic mutations, copy number variations, gene expression, and DNA methylation.
Certifications have been awarded to the McGill University and Genome Quebec Innovation Centre in Montreal, Knight Diagnostic Laboratories at Oregon Health and Science University, and GeneWorks in Adelaide, Australia. Additional institutions have included The Clinical Genomics Centre in Toronto, Karolinska University Hospital in Sweden, NewGene in Newcastle, UK, DNA LandMarks (a plant and animal genomics company and subsidiary of BASF) in Quebec, and several providers based in Asia.
Sequenom, 858-202-9000